China SXT Pharmaceuticals (SXTC) Short-term Investments (2018 - 2025)

China SXT Pharmaceuticals' Short-term Investments history runs 6 years deep, the most recent figure standing at $31001.0 for Q3 2025.

• In Q3 2025, Short-term Investments changed N/A year-over-year to $31001.0; the TTM figure through Sep 2025 stood at $31001.0 (changed N/A YoY), while the FY2025 annual figure was $30413.0, up 344.5% from the prior year.
• Short-term Investments was $31001.0 for Q3 2025 at China SXT Pharmaceuticals, up from $30413.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $45297.0 in Q1 2022 to a low of $6842.0 in Q1 2024.
• Historically, Short-term Investments has averaged $27900.0 across 4 years, with a median of $30413.0 in 2025.
• The sharpest annual moves came in 2022 and 2025: Short-term Investments surged 74.58% in 2022, then soared 344.5% in 2025.
• A 4-year view of Short-term Investments shows it stood at $25947.0 in 2021, then soared by 74.58% to $45297.0 in 2022, then plunged by 84.9% to $6842.0 in 2024, then surged by 353.1% to $31001.0 in 2025.
• The last three Short-term Investments figures came in at $31001.0 (Q3 2025), $30413.0 (Q1 2025), and $6842.0 (Q1 2024), per Business Quant data.